• Dorzolamide/timolol Viatris 20 mg/ml + 5 mg/ml eye drops

  Form: solution, ophthalmic

  Active substance	Dosage
  DORZOLAMIDE HYDROCHLORIDE	111,30 mg
  TIMOLOL MALEATE	34,15 mg

  ATC: S01E S01ED S01ED51

• Doxazosin Neo Viatris 4 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,85 mg

  ATC: C02C C02CA C02CA04

• Doxazosin Neo Viatris 8 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	9,7 mg

  ATC: C02C C02CA C02CA04

• Doxazosin Viatris Pharmaceuticals 4 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,852 mg

  ATC: C02C C02CA C02CA04

• Dutasteride/tamsulosin Viatris 0.5 mg/0.4 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  DUTASTERIDE	0,5 mg
  TAMSULOSIN HYDROCHLORide	0,4 mg

  ATC: G04C G04CA G04CA52

• Ebastine Viatris 20 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  EBASTINE	20 mg

  ATC: R06A R06AX R06AX22

• Eltrombopag Viatris 25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ELTROMBOPAG OLAMINE	31,90 mg

  ATC: B02B B02BX B02BX05

• Eltrombopag Viatris 50 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ELTROMBOPAG OLAMINE	63,80 mg

  ATC: B02B B02BX B02BX05

• Enalapril Viatris 20 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  ENALAPRIL MALEATE	20 mg

  ATC: C09A C09AA C09AA02

• Enalapril Viatris 5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  ENALAPRIL MALEATE	5 mg

  ATC: C09A C09AA C09AA02

• Entacapone Viatris 200 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ENTACAPONE	200,000 mg

  ATC: N04B N04BX N04BX02

• Eplerenone Viatris 25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  EPLERENONE	25 mg

  ATC: C03D C03DA C03DA04

• Eplerenone Viatris 50 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  EPLERENONE	50 mg

  ATC: C03D C03DA C03DA04

• Escitalopram Viatris 10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ESCITALOPRAM OXALATE	6,39 mg

  ATC: N06A N06AB N06AB10

• Escitalopram Viatris 15 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ESCITALOPRAM OXALATE	6,39 mg

  ATC: N06A N06AB N06AB10

• Escitalopram Viatris 20 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ESCITALOPRAM OXALATE	6,39 mg

  ATC: N06A N06AB N06AB10

• Esomeprazole Viatris 20 mg gastro-resistant tablets EFG

  Form: tablets, enteric-coated

  Active substance	Dosage
  ESOMEPRAZOLE MAGNESIUM	20,700 mg

  ATC: A02B A02BC A02BC05

• Esomeprazole Viatris 40 mg gastro-resistant tablets EFG

  Form: tablets, enteric-coated

  Active substance	Dosage
  ESOMEPRAZOLE MAGNESIUM	41,400 mg

  ATC: A02B A02BC A02BC05

• Etoricoxib Viatris 120 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ETORICOXIB	120,000 mg

  ATC: M01A M01AH M01AH05

• Etoricoxib Viatris 30 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ETORICOXIB	30,000 mg

  ATC: M01A M01AH M01AH05

• Etoricoxib Viatris 60 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ETORICOXIB	60,000 mg

  ATC: M01A M01AH M01AH05

• Etoricoxib Viatris 90 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  ETORICOXIB	90,000 mg

  ATC: M01A M01AH M01AH05

• Everolimus Viatris 10 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  EVEROLIMUS	10 mg

  ATC: L01E L01EG L01EG02

• Everolimus Viatris 5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  EVEROLIMUS	5 mg

  ATC: L01E L01EG L01EG02

• Exemestane Viatris 25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  EXEMESTANE	25 mg

  ATC: L02B L02BG L02BG06

• Ezetimibe Viatris 10 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  EZETIMIBE	10 mg

  ATC: C10A C10AX C10AX09

• Ezetimibe/simvastatin Viatris 10 mg/20 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  SIMVASTATIN	20,000 mg
  EZETIMIBE	10,000 mg

  ATC: C10B C10BA C10BA02

• Ezetimibe/simvastatin Viatris 10 mg/40 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  SIMVASTATIN	40,000 mg
  EZETIMIBE	10,000 mg

  ATC: C10B C10BA C10BA02

• Fentanyl Matrix Viatris 100 mcg/h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  FENTANYL	16,80 mg

  ATC: N02A N02AB N02AB03

• Fentanyl Matrix Viatris 25 mcg/h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  FENTANYL	4,20 mg

  ATC: N02A N02AB N02AB03

• Fentanyl Matrix Viatris 50 mcg/h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  FENTANYL	8,40 mg

  ATC: N02A N02AB N02AB03

• Fentanyl Matrix Viatris 75 mcg/h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  FENTANYL	12,60 mg

  ATC: N02A N02AB N02AB03

• Ferric carboxymaltose Viatris 50 mg/ml injection and infusion dispersion

  Form: solution for injection and infusion

  Active substance	Dosage
  IRON CARBOXYMALTOSE	0,357 g

  ATC: B03A B03AC

• Finasteride Viatris 1 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  FINASTERIDE	1,0 mg

  ATC: D11A D11AX D11AX10

• Fluoxetine Viatris 20 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  FLUOXETINE HYDROCHLORIDE	22,36 mg

  ATC: N06A N06AB N06AB03

• Fluvastatin Viatris 20 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  FLUVASTATIN SODIUM	21,95 mg

  ATC: C10A C10AA C10AA04

• Fluvastatin Viatris 40 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  FLUVASTATIN SODIUM	43,9 mg

  ATC: C10A C10AA C10AA04

• Fluvastatin Viatris 80 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  FLUVASTATIN SODIUM	84,48 mg

  ATC: C10A C10AA C10AA04

• Galantamine Viatris 16 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  GALANTAMINE HYDROBROMIDE	20,512 mg

  ATC: N06D N06DA N06DA04

• Galantamine Viatris 24 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  GALANTAMINE HYDROBROMIDE	30,768 mg

  ATC: N06D N06DA N06DA04

• Galantamine Viatris 8 mg prolonged-release hard capsules EFG

  Form: capsules, hard, prolonged release

  Active substance	Dosage
  GALANTAMINE HYDROBROMIDE	10,256 mg

  ATC: N06D N06DA N06DA04

• Glatiramer ViatriS 20 mg/ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  GLATIRAMER ACETATE	20 mg

  ATC: L03A L03AX L03AX13

• Glatiramer ViatriS 40 mg/ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  GLATIRAMER ACETATE	40 mg

  ATC: L03A L03AX L03AX13

• Gliclazide Viatris 30 mg modified-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  GLICLAZIDE	30 mg

  ATC: A10B A10BB A10BB09

• Glimepiride Viatris 2 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  GLIMEPIRIDE	2,0 mg

  ATC: A10B A10BB A10BB12

• Glimepiride Viatris 4 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  GLIMEPIRIDE	4,0 mg

  ATC: A10B A10BB A10BB12

• Ibandronic acid Viatris 150 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  IBANDRONIC ACID	150 mg

  ATC: M05B M05BA M05BA06

• Indapamide prolonged-release tablets ViatriS 1.5 mg EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  INDAPAMIDE	1,50 mg

  ATC: C03B C03BA C03BA11

• Irbesartan Viatris 150 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  IRBESARTAN	150 mg

  ATC: C09C C09CA C09CA04

• Irbesartan Viatris 300 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  IRBESARTAN	300 mg

  ATC: C09C C09CA C09CA04